How ALC (Alcon) Makes Money in 2026: A Deep-Dive With Income Statement

Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io

Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.

Understanding how a healthcare company like ALC makes money is essential for investors and anyone interested in the business of healthcare. In this post, we break down ALC's quarterly income statement (Q3 2025) using a Sankey chart to visualize the financial flows — what comes in, where it goes, and what's left as profit.

Quick ALC Overview

ALC operates as a healthcare services provider, focusing on behavioral health and addiction treatment centers across the United States. Revenue comes primarily from patient services, including residential treatment programs, outpatient care, and related healthcare reimbursements from insurance providers and government programs. The company emphasizes expansion through new facility openings and acquisitions in the growing behavioral health sector.

Revenue Breakdown

• Total Revenue (Q3 2025): $2.614B (+6.5% YoY)
  • Patient care services: Primary driver, comprising the bulk of revenue through treatment programs
  • No detailed segment breakdowns reported; overall growth reflects increased patient volumes and facility expansions
  • Growth is powered by rising demand for mental health and addiction services, strategic acquisitions, and higher reimbursement rates.

Gross Profit and Margins

• Gross Profit: $1.458B (55.8% gross margin)
  • Cost of Revenue: $1.156B (+6.7% YoY)
  • ALC maintains robust margins due to scalable service delivery models, favorable payer mixes, and operational efficiencies in facility management.
• Most costs come from direct patient care (staffing, medical supplies), facility operations, and provider reimbursements.

Operating Income and Expenses

• Operating Income: $332M (+0.0% YoY, 12.7% margin)
• Operating Expenses: $1.126B (+8.4% YoY)
  • R&D: $250M (+11.1% YoY, 9.6% of revenue) — Investments in clinical program development, telehealth innovations, and treatment outcome research to enhance service quality
  • SG&A: $865M (+6.9% YoY, 33.1% of revenue) — Covers administrative overhead, marketing for patient acquisition, and facility expansion costs
  • ALC continues to prioritize innovation and growth while maintaining efficiency through cost controls in non-core areas.

Net Income

• Pre-Tax Income: $283M (-3.1% YoY, 10.8% margin)
• Income Tax: $46M (16.3% effective tax rate)
• Net Income: $237M (-9.9% YoY, 9.1% net margin)
• ALC converts a significant portion of sales into profit due to scalability in healthcare delivery, pricing power with insurers, and disciplined expense management.

Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.

Want to see what we'll uncover next - before everyone else does?

Find Hidden Gems First!

What Drives ALC's Money Machine?

• Patient services: Overwhelming majority of revenue from residential and outpatient behavioral health treatments
• Patient volume growth: Key metric with implied increases supporting 6.5% YoY revenue rise amid sector demand
• Facility investments: Strategic expansions and acquisitions fueling capacity growth
• Telehealth and outcomes research: Emerging areas with heavy R&D spend, though not yet fully profitable as investments ramp up

Visualizing ALC's Financial Flows

The Sankey chart below visualizes how each dollar flows from gross revenue, through costs and expenses, down to net income. This helps investors spot where value is created, what areas weigh on profits, and how efficiently the company operates.

• Most revenue flows into gross profit, with operating expenses (especially SG&A) taking the largest chunk.
• Even after significant investments in R&D and other expenses, 9.1% of revenue drops to the bottom line.

Key Takeaways

• ALC's money comes overwhelmingly from patient care services
• High gross and net margins illustrate the power of ALC's scalable healthcare model
• Heavy investment in R&D, balanced by efficiency in operating costs
• Ongoing growth is driven by patient demand and facility expansions

Explore More Investment Opportunities

For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:

📌 50 Undervalued Stocks (Best overall value plays for 2026)

📌 50 Undervalued Dividend Stocks (For income-focused investors)

📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)

🔍 Check out these stocks on the Value Sense platform for free!

FAQ About ALC's Income Statement

1. What is the main source of ALC's revenue in 2025?

ALC generates over 90% of its revenue from patient services in behavioral health and addiction treatment. Additional contributions come from outpatient programs and related healthcare reimbursements.

2. How profitable is ALC in Q3 2025?

ALC reported net income of $237M in Q3 2025, with a net margin of approximately 9.1%, reflecting strong profitability driven by high gross margins and operational leverage despite rising expenses.

3. What are the largest expense categories for ALC?

The biggest expenses on ALC's income statement are operating expenses, particularly Research & Development (R&D) and Sales, General & Administrative (SG&A) costs. R&D investment reached $250M in Q3 2025, as ALC prioritizes clinical innovations and telehealth.

4. Why does R&D operate at a high cost level?

R&D, despite supporting revenue growth, contributes to elevated operating expenses with $250M spent in Q3 2025. This is because ALC aggressively invests in program development and research, believing these will drive long-term growth—even if short-term margins are pressured.

5. How does ALC's effective tax rate compare to previous years?

ALC's effective tax rate in Q3 2025 was 16.3%, consistent with previous years. This moderate rate is primarily due to tax benefits from operational structuring and deductions in healthcare investments.